The increase in price target by a reputable analyst like Anupam Rama from JP Morgan is a positive signal for investors, indicating a bullish outlook on the stock. This adjustment suggests that the analyst sees potential for higher future performance or valuation of SpringWorks Therapeutics, which could lead to increased investor interest and potentially drive the stock price up in the short term.